ARA-290
Description
ARA-290, also known as Cibinetide, is a synthetic 11-amino acid peptide derived from the three-dimensional structure of erythropoietin (EPO). Unlike EPO itself, ARA-290 selectively activates the innate repair receptor (IRR) a heterodimeric complex of the EPO receptor and CD131 without stimulating red blood cell production. This tissue-protective peptide has demonstrated remarkable effects in preclinical and clinical studies for diabetic neuropathy, sarcoidosis-related small fiber neuropathy, and inflammatory conditions. Its unique mechanism of action offers cytoprotection and promotes tissue repair while avoiding the blood-thickening risks associated with traditional EPO therapy.
Certificate of Analysis
Every batch of ARA-290 is independently lab-tested to a minimum of 98% purity. A Certificate of Analysis is available on request — contact us with your order or lot number and we'll send the COA for your specific batch.
Request a COAResearch Protocol
Full dose-by-dose reconstitution & dosing protocol for ARA-290.
View Research Protocol →Research protocol for this size is coming soon.
For laboratory and scientific research use only. Not medical advice.
For laboratory and research use only. Minimum 98% purity. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.
